🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 24 of 30

  1. US 7300935

    Thienopyrimidine compounds and use thereof

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7294475

    Gene and use thereof

    Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7294344

    Sustained-release preparation for AII antagonist, production and use thereof

    Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7288654

    Fused-ring pyridine derivative, process for producing the same, and use

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7285668

    Process for the crystallization of (R)- or (S)-lansoprazole

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7276527

    5-pyridyl-1,3-azole compounds, process for producing the same and use thereof

    Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7273710

    Method for screening MCH receptor antagonist/agonist

    Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7271182

    Salts of benzimidazole compound and use thereof

    Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7268212

    Ligand of G protein-coupled receptor protein and DNA thereof

    Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7265157

    Sustained release compositions, process for producing the same and use thereof

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7262185

    Benzazepine derivative, process for producing the same, and use

    Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7256279

    Protein having ribonucleotide reductase activity and DNA thereof

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7256204

    Amine compounds, their production and use

    Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7250272

    G protein-coupled receptor protein and DNA thereof

    Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7247653

    Pharmaceutical composition

    Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7247705

    Proteins having glucose transporter activity

    Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7241860

    Transcription factor polypeptide that regulates Chondromodulin-I expression

    Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7241785

    Five-membered heterocyclic alkanoic acid derivative

    Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7238716

    Alkanoic acid derivatives process for their production and use thereof

    Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7235531

    Tachykinin-like polypeptides and use thereof

    Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7229986

    Melanin-concentrating hormone antagonist

    Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7223791

    Function regulator for retinoid relative receptor

    Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7217808

    RFRP-3 and DNA thereof

    Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7214495

    Screening method

    Expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7208495

    Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof

    Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7202040

    Method for screening compounds which change the binding properties of a protein with a ligand

    Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7199124

    JNK inhibitor

    Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7193033

    Peptide having appetite stimulating activity

    Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7189744

    Crystals of benzimidazole compounds

    Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7183415

    Quinoline compound

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7183276

    Azole compounds

    Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7179823

    5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity

    Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7176010

    Isolated human protein having esterase activity and DNA encoding the same

    Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7173112

    Antibody to GALP and uses thereof

    Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7172876

    Method of screening therapeutic agents for nerve degeneration associated diseases

    Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7169799

    Process for producing crystal

    Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7169801

    Histone deacetylase inhibitors

    Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7166762

    Method of constructing heart failure model animal

    Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7160887

    Aromatic amine derivatives, their production and use

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7157259

    Murine lecithin-cholesterol acyltransferase protein

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7157584

    Benzimidazole derivative and use thereof

    Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7153972

    Benzimidazole derivatives, their production and use

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7144720

    Protein and DNA thereof

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7144900

    Pharmaceutical composition

    Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7141598

    Imidazole derivatives, production method thereof and use thereof

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7138533

    Preventives/remedies for urinary disturbance

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7138249

    Screening method

    Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7135490

    Method for the treatment of glomerulonephritis

    Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.